News

More States In Peninsula Receive COVID-19 Vaccine

KUALA LUMPUR, Feb 25 — More states in Peninsular Malaysia are receiving the supply of COVID-19 vaccine, Comirnaty, produced by Pfizer-BioNTech on the second day of the first phase of the National COVID-19 Immunisation Programme.

Negeri Sembilan, Kedah, Melaka, Kelantan, Perak, Pahang and Perlis received the vaccine supply yesterday.

The National COVID-19 Immunisation Programme started yesterday with Prime Minister Tan Sri Muhyiddin Yassin being the first individual to receive the vaccine.

In KEDAH, a DHL lorry carrying 2,340 doses of Pfizer-BioNTech vaccine arrived safely at about 12.40 pm today at the Integrated Pharmacy Logistics Unit store of the Langkawi Health Office at the Air Hangat Clinic.

The lorry had travelled from Penang International Airport to Kuala Perlis Jetty in Perlis before using the RORO ferry service to Tanjung Lembung, Langkawi.

Sources: BERNAMA

Adib Mohd

Recent Posts

Grab Lights Up Times Square With Southeast Asia’s Best, From Nasi Lemak to Pink Beach

Times Square just got a splash of Southeast Asian warmth and Grab is behind it.… Read More

26 minutes ago

FaLaLa 2.0 Brings Snow, Sparkle & Christmas Magic to Andaman Island

Penang is about to get a dreamy holiday makeover. After the buzz of FaLaLa 1.0… Read More

45 minutes ago

Ramen Minamo Just Leveled Up, Chef Chihiro Miyazaki Introduces Must-Try Spicy Beef Miso

In a year that's felt more like a chaotic anime season finale than a smooth… Read More

1 hour ago

Snag These Lazada 12.12 Beauty & Wellness Picks Before They’re Gone

The year’s finale is here, and it’s the perfect time to think of beauty as… Read More

5 hours ago

Pandora’s Butterfly Collection Is Here

This holiday season, Pandora is sprinkling a little extra magic with its butterfly-themed designs that… Read More

6 hours ago

The Internet Just Discovered “Otrovert” And You Might Be One

Personality types have been a staple of self-discovery for decades from Carl Jung’s introvert vs… Read More

6 hours ago

This website uses cookies.